Pro-Dex (NASDAQ:PDEX) Stock Price Crosses Above 200-Day Moving Average of $13.59

Pro-Dex Inc (NASDAQ:PDEX) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $13.59 and traded as high as $15.88. Pro-Dex shares last traded at $15.88, with a volume of 949 shares changing hands.

Separately, ValuEngine upgraded shares of Pro-Dex from a “sell” rating to a “hold” rating in a research report on Monday, November 11th.

The stock has a market cap of $55.89 million, a PE ratio of 15.13 and a beta of 1.51. The company’s 50-day moving average price is $13.47 and its 200 day moving average price is $13.60. The company has a debt-to-equity ratio of 0.22, a quick ratio of 3.81 and a current ratio of 5.74.

A number of hedge funds have recently bought and sold shares of PDEX. Hancock Whitney Corp acquired a new position in shares of Pro-Dex in the 3rd quarter valued at $161,000. Wedge Capital Management L L P NC acquired a new position in Pro-Dex in the second quarter valued at about $267,000. Squarepoint Ops LLC lifted its position in Pro-Dex by 8.2% in the third quarter. Squarepoint Ops LLC now owns 18,500 shares of the medical instruments supplier’s stock valued at $283,000 after buying an additional 1,400 shares during the last quarter. Seizert Capital Partners LLC purchased a new position in Pro-Dex during the second quarter worth about $318,000. Finally, Marshall Wace LLP purchased a new position in Pro-Dex during the second quarter worth about $328,000. 15.71% of the stock is owned by institutional investors.

About Pro-Dex (NASDAQ:PDEX)

Pro-Dex, Inc, together with its subsidiaries, designs, develops, and manufactures powered surgical instruments, dental instruments, and rotary air motors worldwide. It also manufactures plastic injection molds for various industries; and shavers and machined parts. In addition, it provides engineering, and quality and regulatory consulting services.

Featured Story: Growth Stocks, What They Are, What They Are Not

Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with's FREE daily email newsletter.